Last updated 2026-06-18
- Raised $35M funding round led by ALIVE Israel Healthtech Fund, May 2022
- Raised $8M funding round led by OurCrowd, Jan 2021
- Raised $5M funding round, May 2019
Total raised
$53.4M
Last: Grant 2025-05
Stage
Series C
Founded
2017
Headcount
50
HQ
Binyamina-Giv'at Ada, Israel
Sector
Health Tech & Life Sciences
About
OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. The company aims to understand the patient's unique response to therapy to overcome one of the major obstacles in clinical oncology today – resistance to treatment.
OncoHost developed the PROphet platform. Combining bioinformatics, system biology, proteomic pattern recognition and machine learning, PROphet provides clinicians with actionable clinical insights, optimal choice of therapy, and a better understanding of their patients' personalized cancer dynamics.
Funding history · 8 rounds · $53.4M total
2025-05
Grant
$2.8M
2024-03
Undisclosed
2023-12
Undisclosed
2022-05
2021-01
$8.0M
2020-01
Grant
$1.0M
2017-10
$1.6M
Q&A
- What is OncoHost's primary focus?
- OncoHost is a technology company focused on precision diagnostics and predictive biomarker development to improve patient outcomes by understanding and overcoming resistance to cancer treatment.
- What is the name of OncoHost's core technology platform?
- OncoHost developed the PROphet platform, which combines bioinformatics, system biology, proteomic pattern recognition, and machine learning to provide actionable clinical insights.
- When was OncoHost founded?
- OncoHost was founded in April 2017.
- Where is OncoHost's headquarters located?
- OncoHost's headquarters is located in Binyamina-Giv'at Ada, Israel.
- What is OncoHost's total funding raised to date?
- OncoHost has raised a total of $53.4 million USD.
- When was OncoHost's most recent funding round, and who were the lead investors?
- OncoHost secured a Grant round in May 2025, with EIC Accelerator as the lead investor.
- Which investors participated in OncoHost's $35 million funding round in May 2022?
- The $35 million funding round in May 2022 was led by ALIVE Israel Healthtech Fund and also included OurCrowd.
- Who is the CEO of OncoHost?
- Ofer Sharon, MD, is the CEO of OncoHost.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsMoleculesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersPatientsLife SciencesPharmaceuticals
Business model
B2B2CB2BB2C
Highlights
1 PatentsVerified
Tags
pharmaceuticalsoncologycancerpersonalized-medicinediagnosticsdata-analyticsartificial-intelligenceblood-testmachine-learningcancer-therapybioinformaticstreatmentsdecision-supportdigital-healthcarebioconvergenceimmunotherapyclinical-trials
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | oncohost.com |
|---|---|
| linkedin.com/company/18360929 | |
| facebook.com/OncoHost |
Identifiers & details
| Founded | 2017-4 |
|---|---|
| Employees (exact) | 50 |
| Offices | Cary |
Radar intelligence
Patents
| EPO | 10 |
|---|
Publications (Crossref)
| Works | 10 |
|---|
Web history (Wayback)
| Domain | oncohost.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|